Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2021 Jan 13

PMID 33435311

Citations 55

Authors

Kondababu Kurakula

Valerie F E D Smolders

Olga Tura-Ceide

J Wouter Jukema

Paul H A Quax

Marie-Jose Goumans

Affiliations

Soon will be listed here.

Abstract

Pulmonary arterial hypertension (PAH) is a rare, complex, and progressive disease that is characterized by the abnormal remodeling of the pulmonary arteries that leads to right ventricular failure and death. Although our understanding of the causes for abnormal vascular remodeling in PAH is limited, accumulating evidence indicates that endothelial cell (EC) dysfunction is one of the first triggers initiating this process. EC dysfunction leads to the activation of several cellular signalling pathways in the endothelium, resulting in the uncontrolled proliferation of ECs, pulmonary artery smooth muscle cells, and fibroblasts, and eventually leads to vascular remodelling and the occlusion of the pulmonary blood vessels. Other factors that are related to EC dysfunction in PAH are an increase in endothelial to mesenchymal transition, inflammation, apoptosis, and thrombus formation. In this review, we outline the latest advances on the role of EC dysfunction in PAH and other forms of pulmonary hypertension. We also elaborate on the molecular signals that orchestrate EC dysfunction in PAH. Understanding the role and mechanisms of EC dysfunction will unravel the therapeutic potential of targeting this process in PAH.

Citing Articles

Cocrystal pleomorphism-inspired drug nanoassembly for pulmonary-endothelium targeting and pulmonary hypertension treatment.

Zoulikha M, Zou J, Yang P, Wu J, Wu W, Hao K Acta Pharm Sin B. 2025; 15(1):557-570.

PMID: 40041921 PMC: 11873612. DOI: 10.1016/j.apsb.2024.11.008.

Severe COVID-19 Pneumonia, Opportunistic Candida krusei Infection, and Acute Respiratory Distress Syndrome with Pulmonary Arterial Hypertension Treated with Bosentan: A Case Report.

Briones-Claudett K, Briones-Zamora K, Benites Solis J, Huilcapi Borja D, Arteaga Ocana K, Touriz Bonifaz M Am J Case Rep. 2025; 26:e946400.

PMID: 39988835 PMC: 11868965. DOI: 10.12659/AJCR.946400.

Broadening horizons: molecular mechanisms and disease implications of endothelial-to-mesenchymal transition.

Qian C, Dong G, Yang C, Zheng W, Zhong C, Shen Q Cell Commun Signal. 2025; 23(1):16.

PMID: 39789529 PMC: 11720945. DOI: 10.1186/s12964-025-02028-y.

Post-transcriptional regulation of IFI16 promotes inflammatory endothelial pathophenotypes observed in pulmonary arterial hypertension.

Rao R, Yang J, Jiang S, El-Khoury W, Hafeez N, Okawa S Am J Physiol Lung Cell Mol Physiol. 2024; 328(1):L148-L158.

PMID: 39657959 PMC: 11905863. DOI: 10.1152/ajplung.00048.2024.

Harmonising cellular conversations: decoding the vital roles of extracellular vesicles in respiratory system intercellular communications.

Jadamba B, Jin Y, Lee H Eur Respir Rev. 2024; 33(174).

PMID: 39537245 PMC: 11558538. DOI: 10.1183/16000617.0272-2023.

References

Christman B, McPherson C, Newman J, King G, Bernard G, GROVES B . An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med. 1992; 327(2):70-5. DOI: 10.1056/NEJM199207093270202. View

Smolders V, Zodda E, Quax P, Carini M, Barbera J, Thomson T . Metabolic Alterations in Cardiopulmonary Vascular Dysfunction. Front Mol Biosci. 2019; 5:120. PMC: 6349769. DOI: 10.3389/fmolb.2018.00120. View

Santos S, Peinado V, Ramirez J, Morales-Blanhir J, Bastos R, Roca J . Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003; 167(9):1250-6. DOI: 10.1164/rccm.200210-1233OC. View

White R, Meoli D, Swarthout R, Kallop D, Galaria I, Harvey J . Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2007; 293(3):L583-90. DOI: 10.1152/ajplung.00321.2006. View

Hong K, Lee Y, Lee E, Park S, Han C, Beppu H . Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension. Circulation. 2008; 118(7):722-30. PMC: 3920834. DOI: 10.1161/CIRCULATIONAHA.107.736801. View

Spiekerkoetter E, Sung Y, Sudheendra D, Bill M, Aldred M, van de Veerdonk M . Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2015; 192(2):254-7. PMC: 4532822. DOI: 10.1164/rccm.201411-2061LE. View

Vane J, Anggard E, Botting R . Regulatory functions of the vascular endothelium. N Engl J Med. 1990; 323(1):27-36. DOI: 10.1056/NEJM199007053230106. View

Li H, Chen S, Chen Y, Meng Q, Durand J, Oparil S . Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J Appl Physiol (1985). 1994; 77(3):1451-9. DOI: 10.1152/jappl.1994.77.3.1451. View

Huang J, Lu W, Ouyang H, Chen Y, Zhang C, Luo X . Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition. Am J Respir Cell Mol Biol. 2019; 62(1):49-60. PMC: 6938136. DOI: 10.1165/rcmb.2018-0165OC. View

10.

Szulcek R, Happe C, Rol N, Fontijn R, Dickhoff C, Hartemink K . Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage. Am J Respir Crit Care Med. 2016; 193(12):1410-20. PMC: 6915853. DOI: 10.1164/rccm.201506-1231OC. View

11.

Meoli D, Ru Su Y, Brittain E, Robbins I, Hemnes A, Monahan K . The transpulmonary ratio of endothelin 1 is elevated in patients with preserved left ventricular ejection fraction and combined pre- and post-capillary pulmonary hypertension. Pulm Circ. 2017; 8(1):2045893217745019. PMC: 5764145. DOI: 10.1177/2045893217745019. View

12.

Teichert-Kuliszewska K, Kutryk M, Kuliszewski M, Karoubi G, Courtman D, Zucco L . Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res. 2005; 98(2):209-17. DOI: 10.1161/01.RES.0000200180.01710.e6. View

13.

Dai Z, Zhu M, Peng Y, Jin H, Machireddy N, Qian Z . Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension. Am J Respir Crit Care Med. 2018; 198(6):788-802. PMC: 6222462. DOI: 10.1164/rccm.201709-1835OC. View

14.

Liu F, Ventura F, Doody J, Massague J . Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol. 1995; 15(7):3479-86. PMC: 230584. DOI: 10.1128/MCB.15.7.3479. View

15.

Ranchoux B, Harvey L, Ayon R, Babicheva A, Bonnet S, Chan S . Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series). Pulm Circ. 2017; 8(1):2045893217752912. PMC: 5798691. DOI: 10.1177/2045893217752912. View

16.

White K, Dempsie Y, Caruso P, Wallace E, McDonald R, Stevens H . Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA/programmed cell death 4/caspase-3 axis. Hypertension. 2014; 64(1):185-94. DOI: 10.1161/HYPERTENSIONAHA.113.03037. View

17.

Galie N, Manes A, Branzi A . The endothelin system in pulmonary arterial hypertension. Cardiovasc Res. 2004; 61(2):227-37. DOI: 10.1016/j.cardiores.2003.11.026. View

18.

Giaid A, Yanagisawa M, Langleben D, Michel R, Levy R, Shennib H . Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993; 328(24):1732-9. DOI: 10.1056/NEJM199306173282402. View

19.

Cavasin M, Stenmark K, McKinsey T . Emerging roles for histone deacetylases in pulmonary hypertension and right ventricular remodeling (2013 Grover Conference series). Pulm Circ. 2015; 5(1):63-72. PMC: 4405717. DOI: 10.1086/679700. View

20.

Hopper R, Moonen J, Diebold I, Cao A, Rhodes C, Tojais N . In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug. Circulation. 2016; 133(18):1783-94. PMC: 4856565. DOI: 10.1161/CIRCULATIONAHA.115.020617. View